Felix Fermin

Felix Fermin is an experienced professional in marketing and market access within the healthcare industry, currently serving as the Director of Value & Access Strategy at Cytokinetics since July 2022, focusing on cardiology and rare diseases. Previous roles include Director of Payer Marketing at BrightPath Marketing LLC, Associate Director at BridgeBio, and Senior Product Manager at Relypsa. Fermin began a career in market access and reimbursement with positions such as Field Logistics Manager and Therapeutic Accounts Manager, accumulating expertise in rare diseases and cardiology throughout various organizations including ZymoGenetics and Schering-Plough. Education was attained at Stony Brook University.